SyrengeAndhra Pradesh has become first State in the country to launch Auto-Disable Syringes for all clinical purposes. The Health Medical & Family Welfare Department, Government of Andhra Pradesh on Wednesday launched AD Syringes for Patient Safety at a conference at AP Secretariat, Amaravati.

Dr (Col) HS Ratti, an epidemiologist and Project Advisor to Safe Point has applauded the move.

Elated Dr. HS Ratti, said, I congratulate AP Govt. for implementing this important initiative. We are honoured and excited to partner with IAPG (Indian Alliance of Patient Groups) and Govt. of Andhra Pradesh to offer training programs to the healthcare workers of AP on correct and best Injection practices to avoid preventable infections.

Andhra Government in May 2018 passed an order to use Auto-Disable Syringes for all clinical purposes.

India consumes over four billion syringes per year of which an INCLEN study done had found nearly 60 per cent as unsafe and 1/3 being reused. Addressing the unsafe injection practices is an important public health agenda, especially in low and middle income countries.

Dr Jitendar Sharma, Advisor for Health & Medical Technology, Government of AP & MD and CEO of AMTZ, said, With advancement in medical technology the patient safety profile have also changed. While modern technology brings advanced safety it also brings new complexity. Govt. of AP endeavors to find technological solutions to progressively and positively impact the safety of patients and care providers.

Poonam Malakondaiah, Special Chief Secretary, Health, Govt. of AP, said, We have launched numerous interventions like RFID for eliminating errors due to patient identification, Auto-Disable Syringes to reduce infections and many other technological interventions. Govt. of AP remains committed to work with stakeholders to set new quality benchmarks in healthcare.


Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related News